Gene Biotherapeutics, Inc.

CRXMOTCHealthcare

$0.00

+$0.00(+9900.00%)

Market Cap$6493

P/E Ratio—

52W High—

52W Low—

Avg Volume7

Open$0.00

Beta19.29

Employees Ownership Insider Trades

Gene Biotherapeutics, Inc. (CRXM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CRXM · as of Mar 30, 2022

Latest filing snapshot

-1-25.00%vs prior year

Gene Biotherapeutics, Inc. (CRXM) employee data is sourced from the annual SEC 10-K filing. As of 2020, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2020-12-31·Full-time · Global

Total Employees

Change (1Y)

-1

Growth % (1Y)

-25.00%

Revenue / Employee

—

Net Income / Employee

$-172.7K

Market Cap

$0M

CRXM Employee Count

1996 – 2020 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2022-03-30	2020-12-31	3	-1	-25.00%
2021-04-23	2019-12-31	4	-2	-33.33%
2017-07-28	2016-12-31	6	+0	+0.00%
2016-12-29	2015-12-31	6	+3	+100.00%
2015-05-22	2014-12-31	3	-8	-72.73%
2014-04-15	2013-12-31	11	-13	-54.17%
2013-04-05	2012-12-31	24	+9	+60.00%
2012-03-30	2011-12-31	15	+0	+0.00%
2011-04-15	2010-12-31	15	+2	+15.38%
2010-03-16	2009-12-31	13	-30	-69.77%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

GLSHQ

Gelesis Holdings, Inc.

93$0M #2

GNBT

Generex Biotechnology Corporation

15—#3

ACCA

Acacia Diversified Holdings, Inc.

5$0M #4

CRYO

American CryoStem Corporation

4$0M #5

CRXM

Gene Biotherapeutics, Inc.YOU

FPSUF

Capha Pharmaceuticals Inc.

N/A$0M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CRXM peer comparison

About CRXM employees

CRXM Employees · Headcount

Gene Biotherapeutics, Inc. (CRXM) employee data is sourced from the annual SEC 10-K filing. As of 2020, Gene Biotherapeutics, Inc. had 3 full-time employees globally. Full-time employees only. Global consolidated headcount.

Gene Biotherapeutics, Inc.'s workforce decreased by 1 (25.00%) in 2020 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CRXM Employees · 5 questions

As of the latest SEC 10-K filing (2020), Gene Biotherapeutics, Inc. had 3 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Gene Biotherapeutics, Inc. employee counthow many employees does Gene Biotherapeutics, Inc. haveCRXM total employees 2020

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2022-03-30